Mail-order pharmacy for new statin prescriptions achieve better cholesterol control

Control achieved in first 3-15 months of therapy

2011-07-25

(Press-News.org) OAKLAND, Calif. – Kaiser Permanente Northern California patients who obtained new statin prescriptions via a mail-order pharmacy achieved better cholesterol control in the first 3-15 months following the initiation of therapy -- compared to those patients who only obtained their statin prescription from their local Kaiser Permanente Northern California pharmacy.

Greater adjusted rates of LDL-C control in mail-order pharmacy users were seen across all gender and race-ethnicity groups, according to the study that appears in the current online issue of the Journal of General Internal Medicine.

After adjustment for demographic, clinical, and socioeconomic characteristics, as well as for potential unmeasured differences between mail-order and in-person pharmacy users, 85 percent of patients who used the mail-order pharmacy achieved target cholesterol levels, compared to 74.2 percent of patients who only used the local Kaiser Permanente pharmacy.

Previous studies have shown that mail-order pharmacy use is associated with greater medication adherence. However, this is the first study to examine whether mail-order pharmacy use is related to improved cardiovascular risk factor outcomes, according to Julie Schmittdiel, PhD, an investigator with the Kaiser Permanente Division of Research in Oakland, Calif., and the lead author of the study.

"While the findings of this study should be confirmed in a randomized controlled trial, they provide new evidence that mail-order pharmacy use may be associated with improved care and outcomes for patients for risk factors with cardiovascular disease," Schmittdiel said.

"Though mail order may not be right for all patients, this study shows that it is one possible tool in the broader health care system-level toolbox that can help patients meet their medication needs."

At Kaiser Permanente, members have 24/7 access to online pharmacy and pharmacy refills at kp.org using My Health Manager, which can be mailed to them free of shipping charges or made available for pick-up at any Kaiser Permanente pharmacy.

In comparing the effectiveness of mail-order pharmacy vs. local pharmacy use on cholesterol control in new statin users, investigators tapped a study population of 100,298 Kaiser Permanente members who were statin users between Jan. 1, 2005, and Dec. 31, 2007. Statin use was obtained from automated pharmacy records and patients were considered to be new users if they had not recorded use of statin in records prior to the initial statin prescription date.

Greater adherence to these medications by mail-order pharmacy users may reflect improved access to medications, researchers explain. Mail order does not require travel to the local pharmacy, which may provide ease and convenience for patients refilling medications. To address possible selection biases – for example, the possibility that patients who use mail-order pharmacy services are more motivated to take care of their health than patients who do not use such services – researchers conducted additional analyses.to minimize such biases. All analyses, even those accounting for such potential differences, showed a positive, significant association between mail order pharmacy use and cholesterol control.

This study is part of an ongoing body of work analyzing the impact of mail-order pharmacy use on clinical outcomes, and seeks to further understand how health care systems can work with patients to optimize medication use without compromising patient choice or safety.

In a January 2010 study in the American Journal of Managed Care, researchers from UCLA and the Kaiser Permanente Division of Research found that patients with diabetes, high blood pressure or high cholesterol who ordered their medications by mail were more likely to take them as prescribed by their doctors than did patients who obtained them from the local pharmacy.

### Additional authors on the Journal of General Internal Medicine study include Andrew J. Karter, PhD; Wendy Dyer, MS; Melissa Parker, MS; and Connie Uratsu, all with the Kaiser Permanente Division of Research. James Chan, PharmD, PhD, with the Kaiser Permanente Pharmacy Outcomes and Research Group, and O.Kenrik Duru, MD, MSHS, with the UCLA David Geffen School of Medicine, also are co-authors. Funding was provided by the Centers for Disease Control and Prevention (Division of Diabetes Translation) and the National Institute of Diabetes and Digestive Kidney Diseases.

About the Kaiser Permanente Division of Research (http://www.dor.kaiser.org/) The Kaiser Permanente Division of Research conducts, publishes and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and the society at large. It seeks to understand the determinants of illness and well-being and to improve the quality and cost-effectiveness of health care. Currently, DOR's 400-plus staff is working on more than 250 epidemiological and health services research projects.

About Kaiser Permanente Kaiser Permanente is committed to helping shape the future of health care. We are recognized as one of America's leading health care providers and not-for-profit health plans. Founded in 1945, our mission is to provide high-quality, affordable health care services to improve the health of our members and the communities we serve. We currently serve 8.8 million members in nine states and the District of Columbia. Care for members and patients is focused on their total health and guided by their personal physicians, specialists and team of caregivers. Our expert and caring medical teams are empowered and supported by industry-leading technology advances and tools for health promotion, disease prevention, state-of-the art care delivery and world-class chronic disease management. Kaiser Permanente is dedicated to care innovations, clinical research, health education and the support of community health. For more information, go to: www.kp.org/newscenter.

ELSE PRESS RELEASES FROM THIS DATE:

Harvard bioengineers identify the cellular mechanisms of traumatic brain injury

2011-07-25

Cambridge, Mass. – July 22, 2011 – Bioengineers at Harvard have identified, for the very first time, the mechanism for diffuse axonal injury and explained why cerebral vasospasm is more common in blast-induced brain injuries than in brain injuries typically suffered by civilians. The research addresses two major aspects of traumatic brain injury (TBI), with significant implications for the medical treatment of soldiers wounded by explosions. Two papers, published in the journals Proceedings of the National Academy of Sciences (PNAS) and PLoS One, provide the most comprehensive ...

PGA invests in minority golf opportunities

2011-07-25

Los Angeles, CA (JULY 22, 2011) Golf's storied history in the US has long been criticized for its lack of diversity, but the PGA has taken steps to improve minority participation and exposure to the game. Minority participation has increased with the popularity and success of Tiger Woods, and continues today with targeted efforts, say the authors of "Increasing Minority Golf Participation Through PGA Education Initiatives" in the open access journal SAGE Open. One important step in the process included one of the Historically Black Colleges and Universities (HBCUs) being ...

IV fluids may reduce severity of kidney failure in kids with E. coli infection

2011-07-25

AUDIO: Giving intravenous fluids to children infected with E.coli bacteria early in the course of infection appears to lower the odds of kidney failure, according to a new study from researchers... Click here for more information. Infection with E. coli bacteria can wreak havoc in children, leading to bloody diarrhea, fever and kidney failure. But giving children intravenous fluids early in the course of an E. coli O157:H7 infection appears to lower the odds of developing ...

**A*Star scientists discover how to combat hospital-acquired infections and life-threatening toxins**

2011-07-25

A team of scientists from A*STAR's Institute of Molecular and Cell Biology (IMCB) has discovered the secret recipe for 'antidotes' that could neutralize the deadly plant toxin Ricin, widely feared for its bioterrorism potential, as well as the Pseudomonas exotoxin (PE) responsible for the tens of thousands of hospital-acquired infections in immune-compromised patients all over the world. The results of this first ever genome-wide study to understand how the Ricin and PE toxins attack cells may also be useful for designing more effective antidotes against Diphtheria and ...

Battle won against Asian tiger mosquito

2011-07-25

An experimental research carried out in Sant Cugat del Vallès and Rubí, coordinated by researchers from UAB, assessed the efficacy of a combination of strategies to reduce the population of tiger mosquitos (Aedes albopictus). The research began in February 2008. The research focused on monitoring eggs found in small experimental traps. Researchers observed that for the first time, the number of eggs diminished after applying the measures. The strategies began with a visit to the affected areas, where owners were informed on prevention measures and told the importance ...

Drexel study: Misuse of pain medication is pathway to high-risk behaviors

2011-07-25

PHILADELPHIA (July 22, 2011)— A new study by researchers at Drexel University's School of Public Health suggests that abuse of prescription painkillers may be an important gateway to the use of injected drugs such as heroin, among people with a history of using both types of drugs. The study, published in the International Journal of Drug Policy, explores factors surrounding young injection drug users' initiation into the misuse of opioid drugs. Common factors identified in this group included a family history of drug misuse and receiving prescriptions for opioid drugs ...

Signaling molecule identified as essential for maintaining a balanced immune response

2011-07-25

(MEMPHIS, Tenn. – July 22, 2011) St. Jude Children's Research Hospital investigators have identified a signaling molecule that functions like a factory supervisor to ensure that the right mix of specialized T cells is available to fight infections and guard against autoimmune disease. The research also showed the molecule, phosphatase MKP-1, is an important regulator of immune balance. Working in laboratory cell lines and mice with specially engineered immune systems, scientists demonstrated that MKP-1 serves as a bridge between the innate immune response that is the ...

World's largest sheep an international traveler

2011-07-25

NEW YORK (July 22, 2011)—A genetic study of the world's largest sheep species has revealed that the big-horned animals travel extensively across the moutainous borders of Afghanistan, Tajikistan, and China according to Wildlife Conservation Society researchers with the support of the U.S. Agency for International Development (USAID). Using a non-invasive technique that extracts DNA from fecal samples, researchers in WCS's Afghanistan Program found that Marco Polo sheep in the Pamir Mountains of Afghanistan are genetically connected to sheep in neighboring Tajikistan and ...

Fool's gold gives scientists priceless insight into Earth's evolution

2011-07-25

Fool's gold is providing scientists with valuable insights into a turning point in the Earth's evolution, which took place billions of years ago. Scientists are recreating ancient forms of the mineral pyrite – dubbed fool's gold for its metallic lustre – that reveal details of past geological events. Detailed analysis of the mineral is giving fresh insight into the Earth before the Great Oxygenation Event, which took place 2.4 billion years ago. This was a time when oxygen released by early forms of bacteria gave rise to new forms of plant and animal life, transforming ...

Office of Naval Research's TechSolutions program lightens burden for Navy's EOD team

2011-07-25

ARLINGTON, Va. — Designed to cut the 50 pounds of battery devices hauled by the Navy's explosive ordnance disposal (EOD) teams, the Office of Naval Research's (ONR) TechSolutions Program has developed a lightweight power system, which was delivered July. 22. Responding to a request from the Explosive Ordnance Disposal Training and Evaluation Unit (EODTEU) 2 to create a lightweight power device to charge their specialized equipment, TechSolutions partnered with Naval Surface Warfare Center Crane, Ind., and Protonex Technology Corp. to develop the Power Management Kit (PMK) ...

Mail-order pharmacy for new statin prescriptions achieve better cholesterol control

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: